Alzheimer's disease-like changes in herpes simplex virus type 1 infected cells: the case for antiviral therapy.
Itzhaki
Ruth F
RF
Faculty of Life Sciences, The University of Manchester, Manchester, United Kingdom. ruth.itzhaki@manchester.ac.uk
Wozniak
Matthew A
MA
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000517:prevention & control / Q000821:virology*; D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001057:Apolipoproteins E / Q000235:genetics; D002460:Cell Line; D004279:DNA, Viral / Q000032:analysis; D018259:Herpesvirus 1, Human / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D051379:Mice; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D001057:Apolipoproteins E; D004279:DNA, Viral